Bitterman Robert J.'s Insider Trades & SAST Disclosures
Bitterman Robert J.'s most recent trade in Phio Pharmaceuticals Corp was a trade of 15,500 Common Stock, $0.0001 par value done . Disclosure was reported to the exchange on Sept. 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bitterman Robert J..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Chairman, Pres & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 15,500 | 17,832 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 07 Jun 2024 | 1,000 | 20,990 (1%) | 0% | 0.7 | 740 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.75 per share. | 06 Jun 2024 | 1,000 | 19,990 (1%) | 0% | 0.8 | 750 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Bitterman Robert J. | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 26 Feb 2024 | 2,500 | 18,990 (1%) | 0% | 0.9 | 2,275 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Bitterman J. Robert | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.76 per share. | 20 Feb 2024 | 1,804 | 16,490 (0%) | 0% | 0.8 | 1,371 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 30 Jun 2023 | 1,000 | 19,211 (1%) | 0% | 2.8 | 2,840 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 30 Jun 2023 | 1,000 | 18,211 (0%) | 0% | 2.9 | 2,880 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 11,000 | 17,211 (0%) | 0% | 0 | Common stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 14 Dec 2022 | 2,000 | 74,541 (4%) | 0% | 0.4 | 780 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 07 Dec 2022 | 2,000 | 72,541 (3%) | 0% | 0.4 | 780 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.43 per share. | 05 Dec 2022 | 2,000 | 70,541 (3%) | 0% | 0.4 | 860 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 25 Nov 2022 | 2,500 | 68,326 (3%) | 0% | 0.4 | 1,050 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.40 per share. | 25 Nov 2022 | 215 | 68,541 (3%) | 0% | 0.4 | 86 | Common stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director, Interim Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1750.00 per share. | 16 Nov 2022 | 1 | 1 | - | 1750 | 1,750 | Series D Preferred Stock, $0.0001 par value |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 40,000 | 65,826 (3%) | 2% | 0 | Common stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 10,000 | 25,826 (1%) | 0% | 0 | Common stock, $0.0001 par value | |
| Phio Pharmaceuticals Corp | Robert J. Bitterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,000 | 15,826 (0%) | 0% | 0 | Common stock, $0.0001 par value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges